PTC Therapeutics | PTCT - 应收帐款人

股票价格
70.42
每天变化
1.73 2.52%
每月一次
5.56%
每年
56.21%
Q2 预测
66.81


金融业
股票价格
USD
资产
USD 2.9B
现金及等价物
USD 984.65M
销售成本
USD 16.3M
流动资产
USD 2.27B
流动负债
USD 968.43M
债务
USD 286.32M
EBIT
USD -81.62M
EBITDA
USD 20.63M
员工
939
EPS每股收益
USD -1.67
股本和储备
USD -205.31M
销售毛利
USD 148.38M
债务利息支出
USD 50.58M
贷款资金
USD 2.03B
市值
USD 5.26B
净收入
USD -134.97M
营业费用
USD 246.3M
营业利润
USD -81.62M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -139.08M
销售收入
USD 164.7M
销售和管理费用
USD 87.2M
股票
USD 79.65M
贸易债权人
USD 45.49M
应收帐款人
USD 181.62M


应收帐款人 更改 日
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Cytokinetics USD 1.81M 6.6M 2025-09
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Xencor USD 29.3M 7.49M 2025-12